维普期刊资源整合服务平台（V6.5）

100篇 您的检索式：作者名="Grupp M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	βⅢ-Tubulin过表达与ERG融合、PTEN缺失密切相关,是预测前列腺癌进展的独立因素显示文摘前列腺癌是西方国家男性最常见的恶性肿瘤之一。目前确立的预后指标包括Gleason分级、肿瘤范围、术前PSA水平以及临床分期等,但这些参数都不足以使个体化治疗决策达到最优化,为此,作者拟寻找更合适的生物学标记来全面了解前列腺癌的生物学行为。	Tsourlakis M C Weig P Grupp K 陈佳菁林慧余英豪	2014	临床与实验病理学杂志2014，30，6：	6
2	Transforming growth factor-beta in cardiovascular development and function显示文摘	Azhar M Schultz Jel J Grupp I	2003	Cytokine Growth Factor Rev2003，14，：	1
3	A naturalistic visual scanning approach to assess selective attention in major depressive disorder显示文摘	Eizenman M Yu L.H Grupp L		0，，02：	1
4	Indicators for National Scie-nce and Technology Policy:How Robust Are Composite In-dicators显示文摘	Grupp H Mogee M E	2004	Research Policy2004，，33：	1
5	RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets:implications for pediatric immunotherapy显示文摘	Coughlin C M Vance B A Grupp S A	2004	Blood2004，103，6：	1
6	Industrializing fiber lasers显示文摘	Grupp M Seefeld T Vollertsen F BIAS Bremen Germany	2004	Ind Laser Solutions2004，3，：	1
7	Knowledge Transfer in an Innovation Simulation Model显示文摘	Marz S Friedrich-Nishio M Grupp H	2006	Technological Forecasting and Social Change (S0040-1625)2006，73，2：	1
8	Antibody- modified T cells : CARs take the front seat for hematologic malignancies显示文摘	Maus M V Grupp S A Porter D L	2014	Blood2014，123，17：	1
9	Chimeric antigen receptor-modified T ceils for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
10	No influence of the MDR -1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4 -V allele) on dose -adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients 显示文摘	von Ahsen N Richter M Grupp C	2001	Clin Chem2001，47，：	1
11	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
12	显示文摘	Grupp D E Goldman A M	1997	Science1997，276，：	1
13	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，：	1
14	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D eta/	2013	N EnglJ Med2013，368，16：	1
15	Chimeric antigen recep- tor-modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
16	No Influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4 V allele)on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal trans plant recipients显示文摘	Von Ahsen N Richter M Grupp C	2001	Clin Chem2001，47，6：	1
17	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
18	No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V co allele) on doseadjusted eyclosporin Atrough ncentrations or rejection incidence in stable renal transplant recipients 显示文摘	von Ahsen N Richter M Grupp C Ringe B Oellerich M Armstrong VW	2001	Clin Chem2001，47，6：	1
19	No influence of the MDR-l C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporine A trough concentrations or rejection incidence in stable renal transplant recipients显示文摘	VON AHSEN N RICHTER M GRUPP C	2001	Clin Chem2001，47，6：	1
20	No Influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4 V Allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients显示文摘	von Ahsen N Richter M Grupp C	2001	Clin Chem2001，47，6：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示